10 20 30 40 50 60 70 80 1YDV - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER ISOMERASE 24-APR-97 1YDV
TITLE TRIOSEPHOSPHATE ISOMERASE (TIM)
COMPND MOL_ID: 1; COMPND 2 MOLECULE: TRIOSEPHOSPHATE ISOMERASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: TIM; COMPND 5 EC: 5.3.1.1; COMPND 6 ENGINEERED: YES
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PLASMODIUM FALCIPARUM; SOURCE 3 ORGANISM_COMMON: MALARIA PARASITE P. FALCIPARUM; SOURCE 4 ORGANISM_TAXID: 5833; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562
KEYWDS ISOMERASE, GLYCOLYSIS, GLUCONEOGENESIS
EXPDTA X-RAY DIFFRACTION
AUTHOR S.S.VELANKAR,M.R.N.MURTHY
REVDAT 3 24-FEB-09 1YDV 1 VERSN REVDAT 2 01-APR-03 1YDV 1 JRNL REVDAT 1 15-OCT-97 1YDV 0
JRNL AUTH S.S.VELANKER,S.S.RAY,R.S.GOKHALE,S.SUMA,H.BALARAM, JRNL AUTH 2 P.BALARAM,M.R.MURTHY JRNL TITL TRIOSEPHOSPHATE ISOMERASE FROM PLASMODIUM JRNL TITL 2 FALCIPARUM: THE CRYSTAL STRUCTURE PROVIDES JRNL TITL 3 INSIGHTS INTO ANTIMALARIAL DRUG DESIGN. JRNL REF STRUCTURE V. 5 751 1997 JRNL REFN ISSN 0969-2126 JRNL PMID 9261072 JRNL DOI 10.1016/S0969-2126(97)00230-X
REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH J.RANIE,V.P.KUMAR,H.BALARAM REMARK 1 TITL CLONING OF THE TRIOSEPHOSPHATE ISOMERASE GENE OF REMARK 1 TITL 2 PLASMODIUM FALCIPARUM AND EXPRESSION IN REMARK 1 TITL 3 ESCHERICHIA COLI REMARK 1 REF MOL.BIOCHEM.PARASITOL. V. 61 159 1993 REMARK 1 REFN ISSN 0166-6851
REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.0 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 10000000.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0010 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 92.0 REMARK 3 NUMBER OF REFLECTIONS : 24508 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.198 REMARK 3 FREE R VALUE : 0.255 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.200 REMARK 3 FREE R VALUE TEST SET COUNT : 2497 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.005 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 10 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.28 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 83.40 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2008 REMARK 3 BIN R VALUE (WORKING SET) : 0.2500 REMARK 3 BIN FREE R VALUE : 0.3120 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 9.80 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 219 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.021 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3914 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 171 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 19.60 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 14.00 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.23 REMARK 3 ESD FROM SIGMAA (A) : 0.23 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.30 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.27 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.40 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 23.60 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.28 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 2.350 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 3.360 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 4.480 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 6.600 ; 2.500 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PARHCSDX.PRO REMARK 3 PARAMETER FILE 2 : WAT.PAR REMARK 3 PARAMETER FILE 3 : NULL REMARK 3 TOPOLOGY FILE 1 : TOPHCSDX.PRO REMARK 3 TOPOLOGY FILE 2 : WAT.TOP REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: LYS A 12 AND LYS B 12 HAVE POSITIVE REMARK 3 PHI ANGLE WHICH IS IMPORTANT FOR THE ACTIVITY OF THE PROTEIN.
REMARK 4 REMARK 4 1YDV COMPLIES WITH FORMAT V. 3.15, 01-DEC-08
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL.
REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 300 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RUH2R REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : FRANCS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 25936 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 15.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 92.0 REMARK 200 DATA REDUNDANCY : 4.000 REMARK 200 R MERGE (I) : 0.08900 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.30 REMARK 200 COMPLETENESS FOR SHELL (%) : 83.9 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.25200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: X-PLOR 3.0 REMARK 200 STARTING MODEL: TRYPANOSOMAL TIM REMARK 200 REMARK 200 REMARK: NULL
REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.01 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.55 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 10 MG/ML PROTEIN IN 12% PEG 6000 IN REMARK 280 HEPES BUFFER PH 7.5, 1MM DTT EQUILIBRATED AGAINST 24% PEG 6000 REMARK 280 IN HEPES BUFFER PH 7.5, 1MM DTT
REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 49.45500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 23.82000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 49.45500 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 23.82000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL
REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA.
REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3310 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 20410 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -23.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 MET B 1 REMARK 465 ALA B 2
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASN B 156 N - CA - C ANGL. DEV. = -18.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 12 -148.32 51.68 REMARK 500 PHE A 157 2.91 -68.45 REMARK 500 TYR A 208 -85.59 -61.16 REMARK 500 LYS B 12 -144.20 53.52 REMARK 500 ASN B 65 147.69 -178.71 REMARK 500 ASP B 152 73.78 -32.71 REMARK 500 REMARK 500 REMARK: NULL
DBREF 1YDV A 1 248 UNP Q07412 TPIS_PLAFA 1 248 DBREF 1YDV B 1 248 UNP Q07412 TPIS_PLAFA 1 248
SEQADV 1YDV VAL A 163 UNP Q07412 ALA 163 CONFLICT SEQADV 1YDV VAL B 163 UNP Q07412 ALA 163 CONFLICT
SEQRES 1 A 248 MET ALA ARG LYS TYR PHE VAL ALA ALA ASN TRP LYS CYS SEQRES 2 A 248 ASN GLY THR LEU GLU SER ILE LYS SER LEU THR ASN SER SEQRES 3 A 248 PHE ASN ASN LEU ASP PHE ASP PRO SER LYS LEU ASP VAL SEQRES 4 A 248 VAL VAL PHE PRO VAL SER VAL HIS TYR ASP HIS THR ARG SEQRES 5 A 248 LYS LEU LEU GLN SER LYS PHE SER THR GLY ILE GLN ASN SEQRES 6 A 248 VAL SER LYS PHE GLY ASN GLY SER TYR THR GLY GLU VAL SEQRES 7 A 248 SER ALA GLU ILE ALA LYS ASP LEU ASN ILE GLU TYR VAL SEQRES 8 A 248 ILE ILE GLY HIS PHE GLU ARG ARG LYS TYR PHE HIS GLU SEQRES 9 A 248 THR ASP GLU ASP VAL ARG GLU LYS LEU GLN ALA SER LEU SEQRES 10 A 248 LYS ASN ASN LEU LYS ALA VAL VAL CYS PHE GLY GLU SER SEQRES 11 A 248 LEU GLU GLN ARG GLU GLN ASN LYS THR ILE GLU VAL ILE SEQRES 12 A 248 THR LYS GLN VAL LYS ALA PHE VAL ASP LEU ILE ASP ASN SEQRES 13 A 248 PHE ASP ASN VAL ILE LEU VAL TYR GLU PRO LEU TRP ALA SEQRES 14 A 248 ILE GLY THR GLY LYS THR ALA THR PRO GLU GLN ALA GLN SEQRES 15 A 248 LEU VAL HIS LYS GLU ILE ARG LYS ILE VAL LYS ASP THR SEQRES 16 A 248 CYS GLY GLU LYS GLN ALA ASN GLN ILE ARG ILE LEU TYR SEQRES 17 A 248 GLY GLY SER VAL ASN THR GLU ASN CYS SER SER LEU ILE SEQRES 18 A 248 GLN GLN GLU ASP ILE ASP GLY PHE LEU VAL GLY ASN ALA SEQRES 19 A 248 SER LEU LYS GLU SER PHE VAL ASP ILE ILE LYS SER ALA SEQRES 20 A 248 MET SEQRES 1 B 248 MET ALA ARG LYS TYR PHE VAL ALA ALA ASN TRP LYS CYS SEQRES 2 B 248 ASN GLY THR LEU GLU SER ILE LYS SER LEU THR ASN SER SEQRES 3 B 248 PHE ASN ASN LEU ASP PHE ASP PRO SER LYS LEU ASP VAL SEQRES 4 B 248 VAL VAL PHE PRO VAL SER VAL HIS TYR ASP HIS THR ARG SEQRES 5 B 248 LYS LEU LEU GLN SER LYS PHE SER THR GLY ILE GLN ASN SEQRES 6 B 248 VAL SER LYS PHE GLY ASN GLY SER TYR THR GLY GLU VAL SEQRES 7 B 248 SER ALA GLU ILE ALA LYS ASP LEU ASN ILE GLU TYR VAL SEQRES 8 B 248 ILE ILE GLY HIS PHE GLU ARG ARG LYS TYR PHE HIS GLU SEQRES 9 B 248 THR ASP GLU ASP VAL ARG GLU LYS LEU GLN ALA SER LEU SEQRES 10 B 248 LYS ASN ASN LEU LYS ALA VAL VAL CYS PHE GLY GLU SER SEQRES 11 B 248 LEU GLU GLN ARG GLU GLN ASN LYS THR ILE GLU VAL ILE SEQRES 12 B 248 THR LYS GLN VAL LYS ALA PHE VAL ASP LEU ILE ASP ASN SEQRES 13 B 248 PHE ASP ASN VAL ILE LEU VAL TYR GLU PRO LEU TRP ALA SEQRES 14 B 248 ILE GLY THR GLY LYS THR ALA THR PRO GLU GLN ALA GLN SEQRES 15 B 248 LEU VAL HIS LYS GLU ILE ARG LYS ILE VAL LYS ASP THR SEQRES 16 B 248 CYS GLY GLU LYS GLN ALA ASN GLN ILE ARG ILE LEU TYR SEQRES 17 B 248 GLY GLY SER VAL ASN THR GLU ASN CYS SER SER LEU ILE SEQRES 18 B 248 GLN GLN GLU ASP ILE ASP GLY PHE LEU VAL GLY ASN ALA SEQRES 19 B 248 SER LEU LYS GLU SER PHE VAL ASP ILE ILE LYS SER ALA SEQRES 20 B 248 MET
FORMUL 3 HOH *171(H2 O)
HELIX 1 1 LEU A 17 ASN A 29 1 13 HELIX 2 2 SER A 45 LEU A 54 5 10 HELIX 3 3 ALA A 80 ASP A 85 1 6 HELIX 4 4 PHE A 96 LYS A 100 1 5 HELIX 5 5 ASP A 106 ASN A 119 1 14 HELIX 6 6 LEU A 131 GLU A 135 1 5 HELIX 7 7 THR A 139 LYS A 148 1 10 HELIX 8 8 VAL A 151 LEU A 153 5 3 HELIX 9 9 PRO A 178 THR A 195 1 18 HELIX 10 10 GLU A 198 GLN A 203 1 6 HELIX 11 11 CYS A 217 GLN A 222 1 6 HELIX 12 12 ASN A 233 LEU A 236 5 4 HELIX 13 13 GLU A 238 ALA A 247 5 10 HELIX 14 14 LEU B 17 ASN B 29 1 13 HELIX 15 15 SER B 45 LEU B 54 5 10 HELIX 16 16 ALA B 80 ASP B 85 1 6 HELIX 17 17 PHE B 96 TYR B 101 1 6 HELIX 18 18 ASP B 106 ASN B 119 1 14 HELIX 19 19 LEU B 131 GLU B 135 1 5 HELIX 20 20 THR B 139 LYS B 148 1 10 HELIX 21 21 LEU B 167 ALA B 169 5 3 HELIX 22 22 PRO B 178 CYS B 196 1 19 HELIX 23 23 GLU B 198 GLN B 203 1 6 HELIX 24 24 CYS B 217 ILE B 221 1 5 HELIX 25 25 ASN B 233 LEU B 236 5 4 HELIX 26 26 GLU B 238 LYS B 245 5 8
SHEET 1 A 4 GLY A 228 VAL A 231 0 SHEET 2 A 4 PHE A 6 ASN A 10 1 N PHE A 6 O PHE A 229 SHEET 3 A 4 ASP A 38 PRO A 43 1 N ASP A 38 O VAL A 7 SHEET 4 A 4 SER A 60 ILE A 63 1 N SER A 60 O VAL A 41 SHEET 1 B 3 TYR A 90 ILE A 93 0 SHEET 2 B 3 LYS A 122 PHE A 127 1 N LYS A 122 O VAL A 91 SHEET 3 B 3 VAL A 160 TYR A 164 1 N ILE A 161 O ALA A 123 SHEET 1 C 4 GLY B 228 VAL B 231 0 SHEET 2 C 4 TYR B 5 ASN B 10 1 N PHE B 6 O PHE B 229 SHEET 3 C 4 LEU B 37 PRO B 43 1 N ASP B 38 O TYR B 5 SHEET 4 C 4 SER B 60 ILE B 63 1 N SER B 60 O VAL B 41 SHEET 1 D 4 TYR B 90 ILE B 93 0 SHEET 2 D 4 LYS B 122 PHE B 127 1 N LYS B 122 O VAL B 91 SHEET 3 D 4 VAL B 160 TYR B 164 1 N ILE B 161 O ALA B 123 SHEET 4 D 4 ILE B 206 TYR B 208 1 N LEU B 207 O LEU B 162
CRYST1 98.910 47.640 118.430 90.00 108.26 90.00 C 1 2 1 8
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.010110 0.000000 0.003336 0.00000
SCALE2 0.000000 0.020991 0.000000 0.00000
SCALE3 0.000000 0.000000 0.008892 0.00000